search
Back to results

Efficacy and Safety of Asenapine in the Prevention of Recurrence of Mood Episodes in Participants With Bipolar 1 Disorder (P06384)

Primary Purpose

Bipolar 1 Disorder

Status
Completed
Phase
Phase 3
Locations
International
Study Type
Interventional
Intervention
asenapine
placebo
Sponsored by
Forest Laboratories
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Bipolar 1 Disorder

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion criteria:

  • Male, or a female who is not of child-bearing potential or who is non-pregnant, non-lactating, and is using a medically accepted method of contraception.
  • Each participant must be willing and able to provide written informed consent.
  • Each participant must have an identified external contact person or an identified responsible person.
  • Current diagnosis of Bipolar 1 Disorder, and a current manic (Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision [DSM-IV-TR^TM] code 296.4x) or mixed (DSM-IV code 296.6x) episode as determined by a structured clinical interview (Mini International Neuropsychiatric Interview [MINI]) at Screening.
  • Each participant must be confirmed to be experiencing an acute manic or mixed bipolar 1 episode.

Exclusion criteria:

  • Uncontrolled, unstable clinically significant medical condition.
  • Clinically significant abnormal laboratory, vital sign, physical examination, or electrocardiogram findings at Screening.
  • Current primary Axis I disorder other than bipolar 1 disorder.
  • Meets the current DSM-IV-TR^TM criteria for substance abuse or dependence (excluding nicotine).
  • Imminent risk of self-harm or harm to others.

Sites / Locations

  • Forest Investigative Site 3017
  • Forest Investigative Site 3019
  • Forest Investigative Site 3001
  • Forest Investigative Site 3004
  • Forest Investigative Site 3006
  • Forest Investigative Site 3003
  • Forest Investigative Site 3007
  • Forest Investigative Site 3042
  • Forest Investigative Site 3012
  • Forest Investigative Site 3040
  • Forest Investigative Site 3031
  • Forest Investigative Site 3015
  • Forest Investigative Site 3010
  • Forest Investigative Site 3039
  • Forest Investigative Site 3032
  • Forest Investigative Site 3029
  • Forest Investigative Site 3021
  • Forest Investigative Site 3014
  • Forest Investigative Site 3002
  • Forest Investigative Site 3024
  • Forest Investigative Site 3037
  • Forest Investigative Site 3041
  • Forest Investigative Site 3023
  • Forest Investigative Site 3035
  • Forest Investigative Site 3033
  • Forest Investigative Site 3009
  • Forest Investigative Site 3020
  • Forest Investigative Site 3036
  • Forest Investigative Site 3027
  • Forest Investigative Site 3000
  • Forest Investigative Site 3104
  • Forest Investigative Site 3100
  • Forest Investigative Site 3106
  • Forest Investigative Site 3102
  • Forest Investigative Site 3105
  • Forest Investigative Site 3101
  • Forest Investigative Site 3103
  • Forest Investigative Site 3153
  • Forest Investigative Site 3154
  • Forest Investigative Site 3152
  • Forest Investigative Site 3156
  • Forest Investigative Site 3308
  • Forest Investigative Site 3305
  • Forest Investigative Site 3306
  • Forest Investigative Site 3307
  • Forest Investigative Site 3302
  • Forest Investigative Site 3303
  • Forest Investigative Site 3351
  • Forest Investigative Site 3353
  • Forest Investigative Site 3352
  • Forest Investigative Site 3356
  • Forest Investigative Site 3131
  • Forest Investigative Site 3126
  • Forest Investigative Site 3127
  • Forest Investigative Site 3128
  • Forest Investigative Site 3129
  • Forest Investigative Site 3130
  • Forest Investigative Site 3125
  • Forest Investigative Site 3202
  • Forest Investigative Site 3200
  • Forest Investigative Site 3204
  • Forest Investigative Site 3205
  • Forest Investigative Site 3201
  • Forest Investigative Site 3182
  • Forest Investigative Site 3182
  • Forest Investigative Site 3177
  • Forest Investigative Site 3176
  • Forest Investigative Site 3179
  • Forest Investigative Site 3178
  • Forest Investigative Site 3180
  • Forest Investigative Site 3252
  • Forest Investigative Site 3255
  • Forest Investigative Site 3257
  • Forest Investigative Site 3230
  • Forest Investigative Site 3228
  • Forest Investigative Site 3233
  • Forest Investigative Site 3226
  • Forest Investigative Site 3229
  • Forest Investigative Site 3227
  • Forest Investigative Site 3232

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Asenapine

Placebo

Arm Description

All study participants will first receive open-label asenapine and placebo for 12 to 16 weeks before being randomized. After randomization, participants will receive asenapine or placebo (this is the double-blind period) for up to 26 weeks.

All study participants will first receive open-label asenapine and placebo for 12 to 16 weeks before being randomized. After randomization, participants will receive asenapine or placebo (this is the double-blind period) for up to 26 weeks.

Outcomes

Primary Outcome Measures

The time (in days) to recurrence of any mood event during the double-blind treatment period

Secondary Outcome Measures

Full Information

First Posted
July 14, 2011
Last Updated
December 3, 2015
Sponsor
Forest Laboratories
search

1. Study Identification

Unique Protocol Identification Number
NCT01396291
Brief Title
Efficacy and Safety of Asenapine in the Prevention of Recurrence of Mood Episodes in Participants With Bipolar 1 Disorder (P06384)
Official Title
A Double-Blind, Placebo-Controlled Trial of Asenapine in the Prevention of Recurrence of a Mood Episode After Stabilization of an Acute Manic/Mixed Episode in Subjects With Bipolar 1 Disorder (Phase 3B, Protocol P06384)
Study Type
Interventional

2. Study Status

Record Verification Date
December 2015
Overall Recruitment Status
Completed
Study Start Date
December 2011 (undefined)
Primary Completion Date
April 2015 (Actual)
Study Completion Date
June 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Forest Laboratories

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This study is being done to evaluate the efficacy and safety of asenapine as compared to placebo in preventing the recurrence of mood episodes after stabilization of an acute/manic mixed episode in participants with Bipolar 1 Disorder. After a Screening Period, each participant will receive open-label asenapine and matching placebo for 12 to 16 weeks. Participants who meet stabilization criteria may then be randomized into one of the two study arms (asenapine or matching placebo) to receive double-blind treatment for up to an additional 26-weeks.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Bipolar 1 Disorder

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
561 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Asenapine
Arm Type
Experimental
Arm Description
All study participants will first receive open-label asenapine and placebo for 12 to 16 weeks before being randomized. After randomization, participants will receive asenapine or placebo (this is the double-blind period) for up to 26 weeks.
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
All study participants will first receive open-label asenapine and placebo for 12 to 16 weeks before being randomized. After randomization, participants will receive asenapine or placebo (this is the double-blind period) for up to 26 weeks.
Intervention Type
Drug
Intervention Name(s)
asenapine
Other Intervention Name(s)
SCH 900274, Saphris®, Sycrest®, Org 5222
Intervention Description
asenapine, sublingual tablets, 5 to 10 mg twice per day (BID)
Intervention Type
Drug
Intervention Name(s)
placebo
Intervention Description
asenapine-matched placebo, sublingual tablets, BID
Primary Outcome Measure Information:
Title
The time (in days) to recurrence of any mood event during the double-blind treatment period
Time Frame
From Week 12 or 16 to Week 38 or 42

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion criteria: Male, or a female who is not of child-bearing potential or who is non-pregnant, non-lactating, and is using a medically accepted method of contraception. Each participant must be willing and able to provide written informed consent. Each participant must have an identified external contact person or an identified responsible person. Current diagnosis of Bipolar 1 Disorder, and a current manic (Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision [DSM-IV-TR^TM] code 296.4x) or mixed (DSM-IV code 296.6x) episode as determined by a structured clinical interview (Mini International Neuropsychiatric Interview [MINI]) at Screening. Each participant must be confirmed to be experiencing an acute manic or mixed bipolar 1 episode. Exclusion criteria: Uncontrolled, unstable clinically significant medical condition. Clinically significant abnormal laboratory, vital sign, physical examination, or electrocardiogram findings at Screening. Current primary Axis I disorder other than bipolar 1 disorder. Meets the current DSM-IV-TR^TM criteria for substance abuse or dependence (excluding nicotine). Imminent risk of self-harm or harm to others.
Facility Information:
Facility Name
Forest Investigative Site 3017
City
Anaheim
State/Province
California
ZIP/Postal Code
92805
Country
United States
Facility Name
Forest Investigative Site 3019
City
Chino
State/Province
California
ZIP/Postal Code
91710
Country
United States
Facility Name
Forest Investigative Site 3001
City
Escondido
State/Province
California
ZIP/Postal Code
92025
Country
United States
Facility Name
Forest Investigative Site 3004
City
National City
State/Province
California
ZIP/Postal Code
91950
Country
United States
Facility Name
Forest Investigative Site 3006
City
Oakland
State/Province
California
ZIP/Postal Code
94612
Country
United States
Facility Name
Forest Investigative Site 3003
City
Orange
State/Province
California
ZIP/Postal Code
92868
Country
United States
Facility Name
Forest Investigative Site 3007
City
Torrance
State/Province
California
ZIP/Postal Code
90502
Country
United States
Facility Name
Forest Investigative Site 3042
City
Colorado Springs
State/Province
Colorado
ZIP/Postal Code
80910
Country
United States
Facility Name
Forest Investigative Site 3012
City
Jacksonville
State/Province
Florida
ZIP/Postal Code
32256
Country
United States
Facility Name
Forest Investigative Site 3040
City
Kissimmee
State/Province
Florida
ZIP/Postal Code
34741
Country
United States
Facility Name
Forest Investigative Site 3031
City
Leesburg,
State/Province
Florida
ZIP/Postal Code
34748
Country
United States
Facility Name
Forest Investigative Site 3015
City
Miami
State/Province
Florida
ZIP/Postal Code
33126
Country
United States
Facility Name
Forest Investigative Site 3010
City
Tampa
State/Province
Florida
ZIP/Postal Code
33613
Country
United States
Facility Name
Forest Investigative Site 3039
City
Atlanta
State/Province
Georgia
ZIP/Postal Code
30331
Country
United States
Facility Name
Forest Investigative Site 3032
City
Chicago
State/Province
Illinois
ZIP/Postal Code
60640
Country
United States
Facility Name
Forest Investigative Site 3029
City
Schaumburg
State/Province
Illinois
ZIP/Postal Code
60194
Country
United States
Facility Name
Forest Investigative Site 3021
City
Witchita
State/Province
Kansas
ZIP/Postal Code
67207
Country
United States
Facility Name
Forest Investigative Site 3014
City
Gladstone
State/Province
Missouri
ZIP/Postal Code
64118
Country
United States
Facility Name
Forest Investigative Site 3002
City
Albuquerque
State/Province
New Mexico
ZIP/Postal Code
87108
Country
United States
Facility Name
Forest Investigative Site 3024
City
Elmsford
State/Province
New York
ZIP/Postal Code
10523
Country
United States
Facility Name
Forest Investigative Site 3037
City
Avon Lake
State/Province
Ohio
ZIP/Postal Code
44012
Country
United States
Facility Name
Forest Investigative Site 3041
City
Cincinnati
State/Province
Ohio
ZIP/Postal Code
45219
Country
United States
Facility Name
Forest Investigative Site 3023
City
Oklahoma City
State/Province
Oklahoma
ZIP/Postal Code
73112
Country
United States
Facility Name
Forest Investigative Site 3035
City
Oklahoma City
State/Province
Oklahoma
ZIP/Postal Code
73116
Country
United States
Facility Name
Forest Investigative Site 3033
City
Memphis
State/Province
Tennessee
ZIP/Postal Code
38119
Country
United States
Facility Name
Forest Investigative Site 3009
City
Houston
State/Province
Texas
ZIP/Postal Code
77030
Country
United States
Facility Name
Forest Investigative Site 3020
City
Houston
State/Province
Texas
ZIP/Postal Code
77090
Country
United States
Facility Name
Forest Investigative Site 3036
City
Irving
State/Province
Texas
ZIP/Postal Code
75062
Country
United States
Facility Name
Forest Investigative Site 3027
City
Plano
State/Province
Texas
ZIP/Postal Code
75093
Country
United States
Facility Name
Forest Investigative Site 3000
City
Wichita Falls
State/Province
Texas
ZIP/Postal Code
76309
Country
United States
Facility Name
Forest Investigative Site 3104
City
Sofia
State/Province
Sofia-Grad
ZIP/Postal Code
1000
Country
Bulgaria
Facility Name
Forest Investigative Site 3100
City
Sofia
State/Province
Sofia-Grad
ZIP/Postal Code
1202
Country
Bulgaria
Facility Name
Forest Investigative Site 3106
City
Sofia
State/Province
Sofia-Grad
ZIP/Postal Code
1632
Country
Bulgaria
Facility Name
Forest Investigative Site 3102
City
Bourgas
ZIP/Postal Code
8000
Country
Bulgaria
Facility Name
Forest Investigative Site 3105
City
Pleven
ZIP/Postal Code
5800
Country
Bulgaria
Facility Name
Forest Investigative Site 3101
City
Varna
ZIP/Postal Code
9010
Country
Bulgaria
Facility Name
Forest Investigative Site 3103
City
Varna
ZIP/Postal Code
9010
Country
Bulgaria
Facility Name
Forest Investigative Site 3153
City
Zagreb
State/Province
Grad Zagreb
ZIP/Postal Code
10000
Country
Croatia
Facility Name
Forest Investigative Site 3154
City
Zagreb
State/Province
Grad Zagreb
ZIP/Postal Code
10000
Country
Croatia
Facility Name
Forest Investigative Site 3152
City
Zagreb
State/Province
Grad Zagreb
ZIP/Postal Code
10090
Country
Croatia
Facility Name
Forest Investigative Site 3156
City
Rijeka
ZIP/Postal Code
51000
Country
Croatia
Facility Name
Forest Investigative Site 3308
City
Nashik
State/Province
Andhra Pradesh
ZIP/Postal Code
422101
Country
India
Facility Name
Forest Investigative Site 3305
City
Ahmedabad
State/Province
Gujaratc
ZIP/Postal Code
380013
Country
India
Facility Name
Forest Investigative Site 3306
City
Ahmedabad
State/Province
Gujarat
ZIP/Postal Code
380-006
Country
India
Facility Name
Forest Investigative Site 3307
City
Nashik
State/Province
Madhya Pradesh
ZIP/Postal Code
422101
Country
India
Facility Name
Forest Investigative Site 3302
City
Kanpur
State/Province
Uttar Pradesh
ZIP/Postal Code
208005
Country
India
Facility Name
Forest Investigative Site 3303
City
Hyderabad
ZIP/Postal Code
500034
Country
India
Facility Name
Forest Investigative Site 3351
City
Manila
State/Province
National Capital Region
ZIP/Postal Code
1000
Country
Philippines
Facility Name
Forest Investigative Site 3353
City
Cebu
ZIP/Postal Code
6000
Country
Philippines
Facility Name
Forest Investigative Site 3352
City
Iloilo
ZIP/Postal Code
5000
Country
Philippines
Facility Name
Forest Investigative Site 3356
City
Mandaluyong
ZIP/Postal Code
1553
Country
Philippines
Facility Name
Forest Investigative Site 3131
City
Targoviste
State/Province
Dâmboviţa
ZIP/Postal Code
130086
Country
Romania
Facility Name
Forest Investigative Site 3126
City
Targu Mureş
State/Province
Mureş
ZIP/Postal Code
540139
Country
Romania
Facility Name
Forest Investigative Site 3127
City
Arad
ZIP/Postal Code
310022
Country
Romania
Facility Name
Forest Investigative Site 3128
City
Bucureşti
ZIP/Postal Code
011426
Country
Romania
Facility Name
Forest Investigative Site 3129
City
Bucureşti
ZIP/Postal Code
041914
Country
Romania
Facility Name
Forest Investigative Site 3130
City
Bucureşti
ZIP/Postal Code
041914
Country
Romania
Facility Name
Forest Investigative Site 3125
City
Iaşi
ZIP/Postal Code
700282
Country
Romania
Facility Name
Forest Investigative Site 3202
City
Moscow
State/Province
Moskva
ZIP/Postal Code
107076
Country
Russian Federation
Facility Name
Forest Investigative Site 3200
City
Moscow
State/Province
Moskva
ZIP/Postal Code
115419
Country
Russian Federation
Facility Name
Forest Investigative Site 3204
City
Smolensk
State/Province
Smolenskaya oblast
ZIP/Postal Code
214019
Country
Russian Federation
Facility Name
Forest Investigative Site 3205
City
Kazan
ZIP/Postal Code
420012
Country
Russian Federation
Facility Name
Forest Investigative Site 3201
City
Saint Petersburg
ZIP/Postal Code
190005
Country
Russian Federation
Facility Name
Forest Investigative Site 3182
City
Belgrade
State/Province
Beograd
ZIP/Postal Code
11000
Country
Serbia
Facility Name
Forest Investigative Site 3182
City
Novi Knezevac
State/Province
Vojvodina
ZIP/Postal Code
23330
Country
Serbia
Facility Name
Forest Investigative Site 3177
City
Belgrade
ZIP/Postal Code
11000
Country
Serbia
Facility Name
Forest Investigative Site 3176
City
Beograd
ZIP/Postal Code
11000
Country
Serbia
Facility Name
Forest Investigative Site 3179
City
Beograd
ZIP/Postal Code
11000
Country
Serbia
Facility Name
Forest Investigative Site 3178
City
Kragujevac
ZIP/Postal Code
34000
Country
Serbia
Facility Name
Forest Investigative Site 3180
City
Kragujevac
ZIP/Postal Code
34000
Country
Serbia
Facility Name
Forest Investigative Site 3252
City
Korucuk
State/Province
Adapazari
ZIP/Postal Code
54290
Country
Turkey
Facility Name
Forest Investigative Site 3255
City
Ankara
ZIP/Postal Code
06100
Country
Turkey
Facility Name
Forest Investigative Site 3257
City
Diyarbakir
ZIP/Postal Code
21280
Country
Turkey
Facility Name
Forest Investigative Site 3230
City
Chernihiv
State/Province
Chernihiv Oblast
ZIP/Postal Code
14000
Country
Ukraine
Facility Name
Forest Investigative Site 3228
City
Kharkiv
State/Province
Kharkiv Oblast
ZIP/Postal Code
61068
Country
Ukraine
Facility Name
Forest Investigative Site 3233
City
Kherson
ZIP/Postal Code
73488
Country
Ukraine
Facility Name
Forest Investigative Site 3226
City
Kyiv
ZIP/Postal Code
01030
Country
Ukraine
Facility Name
Forest Investigative Site 3229
City
Kyiv
ZIP/Postal Code
254655
Country
Ukraine
Facility Name
Forest Investigative Site 3227
City
Luhansk
ZIP/Postal Code
91045
Country
Ukraine
Facility Name
Forest Investigative Site 3232
City
Lviv
ZIP/Postal Code
79010
Country
Ukraine

12. IPD Sharing Statement

Citations:
PubMed Identifier
28946761
Citation
Szegedi A, Durgam S, Mackle M, Yu SY, Wu X, Mathews M, Landbloom RP. Randomized, Double-Blind, Placebo-Controlled Trial of Asenapine Maintenance Therapy in Adults With an Acute Manic or Mixed Episode Associated With Bipolar I Disorder. Am J Psychiatry. 2018 Jan 1;175(1):71-79. doi: 10.1176/appi.ajp.2017.16040419. Epub 2017 Sep 26.
Results Reference
derived

Learn more about this trial

Efficacy and Safety of Asenapine in the Prevention of Recurrence of Mood Episodes in Participants With Bipolar 1 Disorder (P06384)

We'll reach out to this number within 24 hrs